Join us at the Society for Clinical Research Sites’ (SCRS) Global Site Solutions Summit, the signature event committed to being “the site’s meeting.” As a Global Impact Partner (GIP) with SCRS and a premier sponsor of the event, we are excited to showcase how our site network can bring your new treatments to patients.

Our Albuquerque site is excited to join the Walk to End Alzheimer’s®, further strengthening our commitment to fighting Alzheimer’s disease. With a strong partnership with the Alzheimer’s Association - New Mexico chapter, we are proud to support this cause that brings hope, care, and progress to those affected by Alzheimer’s. We invite you to walk with us, support our efforts, and help make a difference. Together, we can show our community’s commitment to ending Alzheimer’s and bring hope to families impacted by this disease.

Our Phoenix site is excited to join the thousands of participants across the country in this important cause. By walking together, we aim to support the Alzheimer’s Association’s mission of advancing research efforts and working toward a future without Alzheimer’s. Let’s walk together, show our support, and bring hope to those affected by Alzheimer’s. Together, we can make a powerful impact!

ObesityWeek® 2024 is the leading international conference for obesity researchers and clinicians. Representing our team will be Jalene Barnhart, Senior Director of Business Development; Tiffany Harden, San Antonio Site Director; and Dr. Lisa Blair, Principal Investigator. Our team’s experience encompasses obesity, with or without associated co-morbidities, and its influence on cardiovascular outcomes. We invite you to set up a meeting with our team during the conference to explore how we can collaborate on advancing obesity research and treatment. Contact us today to schedule a time to connect.

The CNS Summit is where top decision-makers gather to explore advancements in CNS clinical research. This year, Kevin Short, Director of Business Development, and Alyssa Boschen, PA-C, MMS, CPI, Regional Site Director, will represent our team. We have extensive experience with CNS indications, including Alzheimer’s disease, ADHD, major depressive disorder, schizophrenia, and more. Set up a meeting at the summit to discuss how we can advance CNS research together.

The NASH-TAG Conference unites leaders in clinical, academic, and pharmaceutical fields to improve outcomes for patients with NASH. IMA Clinical Research is a recognized leader in NASH studies, building a large patient database through community partnerships. With advanced imaging capabilities and high enrollment rates, especially in diverse communities, we are at the forefront of NASH research. Connect with our team—Kevin Short and Dr. Yu-Mei Liu—to discuss how our site network can bring new NASH treatments to patients.